As part of The Wistar Institute's Melanoma Research Center, the Villanueva lab pursues new ways to overcome the challenge of melanoma drug resistance. In this paper, the group took aim at melanomas ...
The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant ...
Reported recurrence rates of lentigo maligna treated with Mohs micrographic surgery have ranged from 0.5 to 30.0% in the ...
As part of The Wistar Institute’s Melanoma Research Center, the Villanueva lab pursues new ways to overcome the challenge of melanoma drug resistance. In this paper, the group took aim at melanomas ...
News Medical on MSN2d
Inhibiting S6K2 gene offers potential treatment for drug-resistant melanomaThe lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant melanoma: inhibiting the gene S6K2. .
Learn how melanoma impacts African Americans, highlighting detection challenges, survival disparities, and prevention ...
More than one-quarter of blood or marrow transplant survivors developed cutaneous malignant neoplasms, according to study results.Researchers identified several risk factors, including older age, ...
A WOMAN has shared how she found a worryingly small early symptom of cancer on her husband’s toenail – which was dismissed by doctors as a fungal infection. David Edges wasn’t concerned when a ...
Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally advanced tumors in particular can be difficult to treat surgically. A ...
Medical Xpress on MSN16d
Melanoma study identifies a mechanism for eliminating harmful cells from cancer treatmentAfter treating a tumor with chemotherapy and radiotherapy, cells known as senescent cells can appear. These are cells that do not divide, are involved in the aging process, and are resistant to cell ...
Targeted cancer drugs work by targeting the differences in cancer cells that help them to grow and survive. Other drugs help the immune system to attack the cancer. They are called immunotherapies.
The following is a summary of “Skin cancer risk in over 200.000 patients with haematologic malignancies in 30 years; a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback